Zevin Asset Management LLC Novartis Ag Transaction History

Zevin Asset Management LLC

  • $647 Million
  • Q3 2024

A detailed history of Zevin Asset Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Zevin Asset Management LLC holds 87,936 shares of NVS stock, worth $9.17 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
87,936
Previous 88,442 0.57%
Holding current value
$9.17 Million
Previous $9.42 Million 7.41%
% of portfolio
1.56%
Previous 1.52%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$106.13 - $120.89 $53,701 - $61,170
-506 Reduced 0.57%
87,936 $10.1 Million
Q2 2024

Jul 29, 2024
SELL
$92.57 - $107.37 $212,540 - $246,521
-2,296 Reduced 2.53%
88,442 $9.42 Million
Q1 2024

May 09, 2024
BUY
$95.27 - $108.47 $520,555 - $592,680
5,464 Added 6.41%
90,738 $8.78 Million
Q4 2023

Feb 07, 2024
SELL
$92.27 - $101.54 $37,830 - $41,631
-410 Reduced 0.48%
85,274 $8.61 Million
Q3 2023

Nov 07, 2023
BUY
$94.73 - $105.13 $221,762 - $246,109
2,341 Added 2.81%
85,684 $8.73 Million
Q2 2023

Aug 07, 2023
BUY
$92.52 - $104.91 $74,478 - $84,452
805 Added 0.98%
83,343 $8.41 Million
Q1 2023

May 05, 2023
SELL
$80.03 - $92.81 $588,220 - $682,153
-7,350 Reduced 8.18%
82,538 $7.59 Million
Q4 2022

Feb 07, 2023
BUY
$75.55 - $92.52 $70,790 - $86,691
937 Added 1.05%
89,888 $8.16 Million
Q3 2022

Nov 08, 2022
BUY
$74.61 - $87.26 $941,578 - $1.1 Million
12,620 Added 16.53%
88,951 $6.76 Million
Q2 2022

Aug 08, 2022
BUY
$80.52 - $93.75 $18,358 - $21,375
228 Added 0.3%
76,331 $6.45 Million
Q1 2022

May 05, 2022
BUY
$80.11 - $90.62 $1.16 Million - $1.31 Million
14,489 Added 23.52%
76,103 $6.68 Million
Q4 2021

Jan 27, 2022
SELL
$79.7 - $88.13 $949,306 - $1.05 Million
-11,911 Reduced 16.2%
61,614 $5.39 Million
Q3 2021

Nov 10, 2021
BUY
$81.78 - $95.14 $622,672 - $724,395
7,614 Added 11.55%
73,525 $6.01 Million
Q2 2021

Aug 09, 2021
BUY
$85.24 - $94.15 $275,495 - $304,292
3,232 Added 5.16%
65,911 $6.01 Million
Q1 2021

May 10, 2021
BUY
$83.5 - $98.47 $465,596 - $549,068
5,576 Added 9.76%
62,679 $5.36 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $188,617 - $228,142
2,416 Added 4.42%
57,103 $5.39 Million
Q3 2020

Nov 04, 2020
SELL
$82.14 - $91.0 $9,610 - $10,647
-117 Reduced 0.21%
54,687 $4.76 Million
Q2 2020

Aug 06, 2020
SELL
$80.93 - $91.1 $66,119 - $74,428
-817 Reduced 1.47%
54,804 $4.79 Million
Q1 2020

May 07, 2020
BUY
$70.67 - $99.01 $466,492 - $653,565
6,601 Added 13.47%
55,621 $4.59 Million
Q4 2019

Feb 06, 2020
BUY
$84.35 - $95.37 $385,732 - $436,127
4,573 Added 10.29%
49,020 $4.64 Million
Q3 2019

Nov 05, 2019
BUY
$85.54 - $94.26 $274,668 - $302,668
3,211 Added 7.79%
44,447 $3.86 Million
Q2 2019

Aug 06, 2019
SELL
$75.4 - $92.8 $496,509 - $611,088
-6,585 Reduced 13.77%
41,236 $3.77 Million
Q1 2019

Apr 29, 2019
BUY
$75.32 - $86.15 $56,941 - $65,129
756 Added 1.61%
47,821 $4.6 Million
Q4 2018

Feb 05, 2019
SELL
$73.66 - $82.02 $1.01 Million - $1.13 Million
-13,758 Reduced 22.62%
47,065 $4.04 Million
Q3 2018

Nov 05, 2018
SELL
$66.94 - $77.43 $83,340 - $96,400
-1,245 Reduced 2.01%
60,823 $5.24 Million
Q2 2018

Aug 08, 2018
SELL
$64.91 - $73.36 $749,061 - $846,574
-11,540 Reduced 15.68%
62,068 $4.69 Million
Q1 2018

Apr 30, 2018
SELL
$70.39 - $84.15 $442,330 - $528,798
-6,284 Reduced 7.87%
73,608 $5.95 Million
Q4 2017

Feb 05, 2018
SELL
$72.33 - $77.64 $331,416 - $355,746
-4,582 Reduced 5.42%
79,892 $6.71 Million
Q3 2017

Oct 30, 2017
BUY
$74.14 - $77.27 $6.26 Million - $6.53 Million
84,474
84,474 $7.25 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Zevin Asset Management LLC Portfolio

Follow Zevin Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zevin Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zevin Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email